Transpharmation
Private Company
Funding information not available
Overview
Transpharmation is a UK-based preclinical neuroscience CRO founded in 2009, offering specialized, translational research services to biopharma clients. It leverages unique assets like a world-class rodent operant platform and a large colony of aged beagles to model human neurological and age-related diseases with high clinical relevance. The company operates as a service provider, generating revenue by supporting external drug discovery programs, and is led by an experienced management team with deep expertise in pharmacology and CRO operations.
Technology Platform
Specialized preclinical CRO platforms including a world-class rodent operant testing system for behavioral pharmacology and a unique naturally occurring disease platform utilizing the world's largest laboratory beagle colony to model age-related human diseases like cognitive decline and osteoarthritic pain.
Opportunities
Risk Factors
Competitive Landscape
Competes within the niche of preclinical neuroscience CROs against other specialty providers and the neuroscience divisions of large, full-service CROs (e.g., Charles River, Labcorp). Its primary differentiation is the exclusive focus on translational models, particularly the aged beagle platform, which is not widely replicated.